Khier, Sonia <br/><br/>
Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.  [electronic resource] 

 -  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences  Jan 2010 
 - 23-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0720 
<br/><br/><label>Standard No.: </label>10.1016/j.ejps.2009.10.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoquinolines--pharmacology<br/>Animals<br/>Antineoplastic Agents--pharmacokinetics<br/>Cell Line, Tumor<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Imidazoles--pharmacokinetics<br/>Imiquimod<br/>Injections, Intraperitoneal<br/>Injections, Intravenous<br/>Male<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Nude<br/>Nitrosourea Compounds--pharmacology<br/>Organophosphorus Compounds--pharmacology<br/>Quinoxalines--administration & dosage<br/>Rats<br/>Skin Neoplasms--drug therapy<br/>Xenograft Model Antitumor Assays